Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.77), $0.01 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Trump: The terms that Iran leaked out to the fake news have nothing to do with the terms that were agreed to
• Oxford Industries (OXM) PT Lowered to $40 at UBS Amid Top-line Weakness
• SpaceX IPO said drew more than $350 billion in total demand - Bloomberg